Long-term tolerability of telcagepant for acute treatment of migraine in a randomized trial

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

Long-term tolerability of telcagepant for acute treatment of migraine in a randomized trial. / Connor, Kathryn M; Aurora, Sheena K; Loeys, Tom; Ashina, Messoud; Jones, Christopher; Giezek, Hilde; Massaad, Rachid; Williams-Diaz, Angela; Lines, Christopher; Ho, Tony W.

In: Headache, Vol. 51, No. 1, 2011, p. 73-84.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Connor, KM, Aurora, SK, Loeys, T, Ashina, M, Jones, C, Giezek, H, Massaad, R, Williams-Diaz, A, Lines, C & Ho, TW 2011, 'Long-term tolerability of telcagepant for acute treatment of migraine in a randomized trial', Headache, vol. 51, no. 1, pp. 73-84. https://doi.org/10.1111/j.1526-4610.2010.01799.x

APA

Connor, K. M., Aurora, S. K., Loeys, T., Ashina, M., Jones, C., Giezek, H., Massaad, R., Williams-Diaz, A., Lines, C., & Ho, T. W. (2011). Long-term tolerability of telcagepant for acute treatment of migraine in a randomized trial. Headache, 51(1), 73-84. https://doi.org/10.1111/j.1526-4610.2010.01799.x

Vancouver

Connor KM, Aurora SK, Loeys T, Ashina M, Jones C, Giezek H et al. Long-term tolerability of telcagepant for acute treatment of migraine in a randomized trial. Headache. 2011;51(1):73-84. https://doi.org/10.1111/j.1526-4610.2010.01799.x

Author

Connor, Kathryn M ; Aurora, Sheena K ; Loeys, Tom ; Ashina, Messoud ; Jones, Christopher ; Giezek, Hilde ; Massaad, Rachid ; Williams-Diaz, Angela ; Lines, Christopher ; Ho, Tony W. / Long-term tolerability of telcagepant for acute treatment of migraine in a randomized trial. In: Headache. 2011 ; Vol. 51, No. 1. pp. 73-84.

Bibtex

@article{488acca54d95483dbee0f93a40b9b965,
title = "Long-term tolerability of telcagepant for acute treatment of migraine in a randomized trial",
abstract = "To evaluate the long-term tolerability of telcagepant for acute treatment of intermittent migraine attacks. Background.- Telcagepant is a calcitonin gene-related peptide (CGRP) receptor antagonist being investigated for the acute treatment of migraine.",
author = "Connor, {Kathryn M} and Aurora, {Sheena K} and Tom Loeys and Messoud Ashina and Christopher Jones and Hilde Giezek and Rachid Massaad and Angela Williams-Diaz and Christopher Lines and Ho, {Tony W}",
note = "{\textcopyright} 2010 American Headache Society.",
year = "2011",
doi = "http://dx.doi.org/10.1111/j.1526-4610.2010.01799.x",
language = "English",
volume = "51",
pages = "73--84",
journal = "Headache",
issn = "0017-8748",
publisher = "Wiley-Blackwell",
number = "1",

}

RIS

TY - JOUR

T1 - Long-term tolerability of telcagepant for acute treatment of migraine in a randomized trial

AU - Connor, Kathryn M

AU - Aurora, Sheena K

AU - Loeys, Tom

AU - Ashina, Messoud

AU - Jones, Christopher

AU - Giezek, Hilde

AU - Massaad, Rachid

AU - Williams-Diaz, Angela

AU - Lines, Christopher

AU - Ho, Tony W

N1 - © 2010 American Headache Society.

PY - 2011

Y1 - 2011

N2 - To evaluate the long-term tolerability of telcagepant for acute treatment of intermittent migraine attacks. Background.- Telcagepant is a calcitonin gene-related peptide (CGRP) receptor antagonist being investigated for the acute treatment of migraine.

AB - To evaluate the long-term tolerability of telcagepant for acute treatment of intermittent migraine attacks. Background.- Telcagepant is a calcitonin gene-related peptide (CGRP) receptor antagonist being investigated for the acute treatment of migraine.

U2 - http://dx.doi.org/10.1111/j.1526-4610.2010.01799.x

DO - http://dx.doi.org/10.1111/j.1526-4610.2010.01799.x

M3 - Journal article

VL - 51

SP - 73

EP - 84

JO - Headache

JF - Headache

SN - 0017-8748

IS - 1

ER -

ID: 40140700